Compare SPIR & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPIR | NPCE |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.1M | 328.8M |
| IPO Year | N/A | 2021 |
| Metric | SPIR | NPCE |
|---|---|---|
| Price | $9.59 | $16.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $14.33 | ★ $17.29 |
| AVG Volume (30 Days) | ★ 459.8K | 248.7K |
| Earning Date | 12-17-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.13 | N/A |
| Revenue | $93,285,000.00 | ★ $94,864,000.00 |
| Revenue This Year | N/A | $24.82 |
| Revenue Next Year | $5.92 | $1.28 |
| P/E Ratio | $8.49 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $6.85 | $7.56 |
| 52 Week High | $21.43 | $18.98 |
| Indicator | SPIR | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 56.64 | 62.47 |
| Support Level | $7.76 | $16.00 |
| Resistance Level | $10.00 | $16.94 |
| Average True Range (ATR) | 0.53 | 0.80 |
| MACD | 0.30 | -0.11 |
| Stochastic Oscillator | 76.87 | 68.23 |
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.